Selected research
Industry Research
Pharmacology Discovery Service Industry Research Report 2026
Market perspective
The global Pharmacology Discovery Service market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Pharmacology Discovery Service market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Pharmacology Discovery Service market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Pharmacology Discovery Service market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Pharmacology Discovery Service include Ichor Life Sciences, Inc, NUVISAN, Porsolt, Charles River Laboratories, Eurofins Discovery, Labcorp, BioDuro-Sundia, Creative Biolabs and BRF, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Pharmacology Discovery Service market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Pharmacology Discovery Service.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Pharmacology Discovery Service Market by Company
Ichor Life Sciences, Inc
NUVISAN
Porsolt
Charles River Laboratories
Eurofins Discovery
Labcorp
BioDuro-Sundia
Creative Biolabs
BRF
WuXi AppTec
Dalriada
Sygnature Discovery
Pharmaron
ChemPartner
NuChem Sciences Inc
Genscript ProBio
Pharmacology Discovery Service Segment by Type
In Vivo Disease Model
Cell Based Assays Service
Drug Discovery Service
Others
Pharmacology Discovery Service Segment by Application
Cardiovascular Disease
Eye Diseases
Autoimmune Diseases
Musculoskeletal Diseases
Other
Pharmacology Discovery Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmacology Discovery Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pharmacology Discovery Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmacology Discovery Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Pharmacology Discovery Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- In Vivo Disease Model
- Cell Based Assays Service
- Drug Discovery Service
- Others
Applications
- Cardiovascular Disease
- Eye Diseases
- Autoimmune Diseases
- Musculoskeletal Diseases
- Other
Companies covered
- Ichor Life Sciences, Inc
- NUVISAN
- Porsolt
- Charles River Laboratories
- Eurofins Discovery
- Labcorp
- BioDuro-Sundia
- Creative Biolabs
- BRF
- WuXi AppTec
- Dalriada
- Sygnature Discovery
- Pharmaron
- ChemPartner
- NuChem Sciences Inc
- Genscript ProBio
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Pharmacology Discovery Service by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 In Vivo Disease Model
- 2.2.3 Cell Based Assays Service
- 2.2.4 Drug Discovery Service
- 2.2.5 Others
- 2.3 Pharmacology Discovery Service by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Cardiovascular Disease
- 2.3.3 Eye Diseases
- 2.3.4 Autoimmune Diseases
- 2.3.5 Musculoskeletal Diseases
- 2.3.6 Other
- 2.4 Assumptions and Limitations
3 Pharmacology Discovery Service Breakdown Data by Type
- 3.1 Global Pharmacology Discovery Service Historic Market Size by Type (2021-2026)
- 3.2 Global Pharmacology Discovery Service Forecasted Market Size by Type (2027-2032)
4 Pharmacology Discovery Service Breakdown Data by Application
- 4.1 Global Pharmacology Discovery Service Historic Market Size by Application (2021-2026)
- 4.2 Global Pharmacology Discovery Service Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Pharmacology Discovery Service Market Perspective (2021-2032)
- 5.2 Global Pharmacology Discovery Service Growth Trends by Region
- 5.2.1 Global Pharmacology Discovery Service Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Pharmacology Discovery Service Historic Market Size by Region (2021-2026)
- 5.2.3 Pharmacology Discovery Service Forecasted Market Size by Region (2027-2032)
- 5.3 Pharmacology Discovery Service Market Dynamics
- 5.3.1 Pharmacology Discovery Service Industry Trends
- 5.3.2 Pharmacology Discovery Service Market Drivers
- 5.3.3 Pharmacology Discovery Service Market Challenges
- 5.3.4 Pharmacology Discovery Service Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Pharmacology Discovery Service Players by Revenue
- 6.1.1 Global Top Pharmacology Discovery Service Players by Revenue (2021-2026)
- 6.1.2 Global Pharmacology Discovery Service Revenue Market Share by Players (2021-2026)
- 6.2 Global Pharmacology Discovery Service Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Pharmacology Discovery Service Head Office and Area Served
- 6.4 Global Pharmacology Discovery Service Players, Product Type & Application
- 6.5 Global Pharmacology Discovery Service Manufacturers Established Date
- 6.6 Global Pharmacology Discovery Service Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Pharmacology Discovery Service Market Size (2021-2032)
- 7.2 North America Pharmacology Discovery Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Pharmacology Discovery Service Market Size by Country (2021-2026)
- 7.4 North America Pharmacology Discovery Service Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Pharmacology Discovery Service Market Size (2021-2032)
- 8.2 Europe Pharmacology Discovery Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Pharmacology Discovery Service Market Size by Country (2021-2026)
- 8.4 Europe Pharmacology Discovery Service Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Pharmacology Discovery Service Market Size (2021-2032)
- 9.2 Asia-Pacific Pharmacology Discovery Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Pharmacology Discovery Service Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Pharmacology Discovery Service Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Pharmacology Discovery Service Market Size (2021-2032)
- 10.2 South America Pharmacology Discovery Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Pharmacology Discovery Service Market Size by Country (2021-2026)
- 10.4 South America Pharmacology Discovery Service Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Pharmacology Discovery Service Market Size (2021-2032)
- 11.2 Middle East & Africa Pharmacology Discovery Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Pharmacology Discovery Service Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Pharmacology Discovery Service Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Ichor Life Sciences, Inc
- 12.1.1 Ichor Life Sciences, Inc Company Information
- 12.1.2 Ichor Life Sciences, Inc Business Overview
- 12.1.3 Ichor Life Sciences, Inc Revenue in Pharmacology Discovery Service Business (2021-2026)
- 12.1.4 Ichor Life Sciences, Inc Pharmacology Discovery Service Product Portfolio
- 12.1.5 Ichor Life Sciences, Inc Recent Developments
- 12.2 NUVISAN
- 12.2.1 NUVISAN Company Information
- 12.2.2 NUVISAN Business Overview
- 12.2.3 NUVISAN Revenue in Pharmacology Discovery Service Business (2021-2026)
- 12.2.4 NUVISAN Pharmacology Discovery Service Product Portfolio
- 12.2.5 NUVISAN Recent Developments
- 12.3 Porsolt
- 12.3.1 Porsolt Company Information
- 12.3.2 Porsolt Business Overview
- 12.3.3 Porsolt Revenue in Pharmacology Discovery Service Business (2021-2026)
- 12.3.4 Porsolt Pharmacology Discovery Service Product Portfolio
- 12.3.5 Porsolt Recent Developments
- 12.4 Charles River Laboratories
- 12.4.1 Charles River Laboratories Company Information
- 12.4.2 Charles River Laboratories Business Overview
- 12.4.3 Charles River Laboratories Revenue in Pharmacology Discovery Service Business (2021-2026)
- 12.4.4 Charles River Laboratories Pharmacology Discovery Service Product Portfolio
- 12.4.5 Charles River Laboratories Recent Developments
- 12.5 Eurofins Discovery
- 12.5.1 Eurofins Discovery Company Information
- 12.5.2 Eurofins Discovery Business Overview
- 12.5.3 Eurofins Discovery Revenue in Pharmacology Discovery Service Business (2021-2026)
- 12.5.4 Eurofins Discovery Pharmacology Discovery Service Product Portfolio
- 12.5.5 Eurofins Discovery Recent Developments
- 12.6 Labcorp
- 12.6.1 Labcorp Company Information
- 12.6.2 Labcorp Business Overview
- 12.6.3 Labcorp Revenue in Pharmacology Discovery Service Business (2021-2026)
- 12.6.4 Labcorp Pharmacology Discovery Service Product Portfolio
- 12.6.5 Labcorp Recent Developments
- 12.7 BioDuro-Sundia
- 12.7.1 BioDuro-Sundia Company Information
- 12.7.2 BioDuro-Sundia Business Overview
- 12.7.3 BioDuro-Sundia Revenue in Pharmacology Discovery Service Business (2021-2026)
- 12.7.4 BioDuro-Sundia Pharmacology Discovery Service Product Portfolio
- 12.7.5 BioDuro-Sundia Recent Developments
- 12.8 Creative Biolabs
- 12.8.1 Creative Biolabs Company Information
- 12.8.2 Creative Biolabs Business Overview
- 12.8.3 Creative Biolabs Revenue in Pharmacology Discovery Service Business (2021-2026)
- 12.8.4 Creative Biolabs Pharmacology Discovery Service Product Portfolio
- 12.8.5 Creative Biolabs Recent Developments
- 12.9 BRF
- 12.9.1 BRF Company Information
- 12.9.2 BRF Business Overview
- 12.9.3 BRF Revenue in Pharmacology Discovery Service Business (2021-2026)
- 12.9.4 BRF Pharmacology Discovery Service Product Portfolio
- 12.9.5 BRF Recent Developments
- 12.10 WuXi AppTec
- 12.10.1 WuXi AppTec Company Information
- 12.10.2 WuXi AppTec Business Overview
- 12.10.3 WuXi AppTec Revenue in Pharmacology Discovery Service Business (2021-2026)
- 12.10.4 WuXi AppTec Pharmacology Discovery Service Product Portfolio
- 12.10.5 WuXi AppTec Recent Developments
- 12.11 Dalriada
- 12.11.1 Dalriada Company Information
- 12.11.2 Dalriada Business Overview
- 12.11.3 Dalriada Revenue in Pharmacology Discovery Service Business (2021-2026)
- 12.11.4 Dalriada Pharmacology Discovery Service Product Portfolio
- 12.11.5 Dalriada Recent Developments
- 12.12 Sygnature Discovery
- 12.12.1 Sygnature Discovery Company Information
- 12.12.2 Sygnature Discovery Business Overview
- 12.12.3 Sygnature Discovery Revenue in Pharmacology Discovery Service Business (2021-2026)
- 12.12.4 Sygnature Discovery Pharmacology Discovery Service Product Portfolio
- 12.12.5 Sygnature Discovery Recent Developments
- 12.13 Pharmaron
- 12.13.1 Pharmaron Company Information
- 12.13.2 Pharmaron Business Overview
- 12.13.3 Pharmaron Revenue in Pharmacology Discovery Service Business (2021-2026)
- 12.13.4 Pharmaron Pharmacology Discovery Service Product Portfolio
- 12.13.5 Pharmaron Recent Developments
- 12.14 ChemPartner
- 12.14.1 ChemPartner Company Information
- 12.14.2 ChemPartner Business Overview
- 12.14.3 ChemPartner Revenue in Pharmacology Discovery Service Business (2021-2026)
- 12.14.4 ChemPartner Pharmacology Discovery Service Product Portfolio
- 12.14.5 ChemPartner Recent Developments
- 12.15 NuChem Sciences Inc
- 12.15.1 NuChem Sciences Inc Company Information
- 12.15.2 NuChem Sciences Inc Business Overview
- 12.15.3 NuChem Sciences Inc Revenue in Pharmacology Discovery Service Business (2021-2026)
- 12.15.4 NuChem Sciences Inc Pharmacology Discovery Service Product Portfolio
- 12.15.5 NuChem Sciences Inc Recent Developments
- 12.16 Genscript ProBio
- 12.16.1 Genscript ProBio Company Information
- 12.16.2 Genscript ProBio Business Overview
- 12.16.3 Genscript ProBio Revenue in Pharmacology Discovery Service Business (2021-2026)
- 12.16.4 Genscript ProBio Pharmacology Discovery Service Product Portfolio
- 12.16.5 Genscript ProBio Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst